Summary: The effects of the centrally acting anti cholinesterases tacrine (tetrahydroaminoacridine, THA) and physostigmine (PHY), on local cerebral glucose uti lization (LCGU) have been studied in 27-month-old rats, using the autoradiographic e4Cjdeoxyglucose technique. THA (10 mg/kg i.p.) increased LCGU significantly in 13 of the 54 regions studied (24%) including insular, parietal, temporal, and retrosplenial cortices, septohippocampal system, thalamus, lateral habenula, and superior collicu Ius. In these regions, the average THA-induced increase in LCGU was 24% above control. The whole brain mean LCGU was not significantly increased. PHY (0. 5 mg/kg) increased LCGU in 18% of the regions (average eleva tion, 23%). The whole brain mean LCGU increased by
The centrally acting cholinesterase inhibitor tet rahydroaminoacridine (THA, tacrine) has been re ported to improve cognitive deficits in subpopula tions of Alzheimer's disease (AD) patients. Several multicenter studies (Eagger et aI., 1991; Davis et aI. , 1992; Farlow et aI., 1992; Knapp et aI., 1994) have confirmed the initial positive results of Sum mers (S ummers et aI., 1986) . The effects of THA in mildly demented AD patients persist during long term treatment and indicate that THA might not only act on symptoms but also delay the disease process (Nordberg et aI., 1992) . The mechanisms mediating the effects of THA are far from clear, but experimental data indicate that THA may produce its therapeutic effects, at least in part, via its action on cholinergic transmission (for review, see Free man and Dawson, 1991) . In experimental animals, 7% (p < 0.05). The regional distributions of THA-and PHY-induced increases in LCGU were extremely similar and overlapped the distribution of the M2 muscarinic re ceptors and that of acetylcholinesterase activity, suggest ing that the major effects of THA and PHY on LCGU result from their anticholinesterase action. As compared to those of 3-month-old rats, both the number of regions affected and the amplitude of the metabolic activation were significantly less in aged rats. However, the drugs were still active in old rats and compensated for the age related hypometabolism in some brain areas. Key Words: Tetrahydroaminoacridine-Physostigmine-Acetylcho line-Cerebral glucose utilization-Aging.
alterations of the cholinergic systems due to phar macological blockade, lesions of the cholinergic projection neurons, or aging are accompanied by cognitive deficits. Administration of anticholines terases such as THA or physostigmine (PHY) to rats with impaired cholinergic activity improves learning and memory (see ref. in Mohammed, 1993) . Metabolic studies have shown that THA and PHY increase local cerebral glucose utilization (LCGU) in a substantial number of brain regions in the rat. The regional topography of the LCGU in crease overlaps the distribution of the M2 musca rinic receptor and that of acetylcholinesterase ac tivity (Bassant et aI., 1993) . In young rats, THA increases glucose utilization in regions where LCGU is decreased in AD patients, such as pari etotemporal cortex (Benson et aI., 1983; de Leon et aI., 1983) . It is important to determine whether the THA-induced increase in LCGU observed in young rats is found also in situations of age-related hypo metabolism. Reduction of brain metabolism has been observed in the aged rat in specific regions including the temporal cortex (Smith et aI., 1980; Wree et aI. , 1991; Bassant et aI., 1994) . Relatively few metabolic studies have compared the pharma-cological responses to drugs acting on the cholin ergic system as a function of age, and no studies have examined the effects of acetylcholinesterase (AChE) inhibitors in the aged rat. The aim of our work was to study the effect of THA (and PHY, a "reference" anticholinesterase) on LCGU in the aged rat and to compare the results to those obtained previously in young animals (Bassant et aI., 1993) .
MATERIALS AND METHODS

Animals
Twenty-one male Sprague-Dawley rats were obtained from IFFA CREDO, France, at 24 months of age and housed in our animal facility for 3 months. The rats were housed (three animals per cage) at 22°C under a 12-h light! dark cycle and had free access to water and food. Ap proximately 40% survived to an age of 27 months (body weight, 640 ± 75 g). None of the aged rats had apparent tumor mass or pituitary adenoma.
Chemicals
THA was obtained from Aldrich (U .S.A.). Physostig mine, scopolamine, hexamethonium bromide, and atro pine methyl bromide were obtained from Sigma (France).
[14CJ2-DeoxY-D-glucose or [14CJDG (specific activity, 50-55 mCilmmol) in ethanol was purchased from Amersham (France). The solution was evaporated under nitrogen, and [14CJDG was resuspended in isotonic saline.
Measurement of local cerebral glucose utilization
LCGU was measured by the quantitative [14CJDG tech nique of Sokoloff et al. (1977) . After 16 h of food depri vation, rats were lightly anesthetized (I % halothane in oxygen), and catheters were inserted in a femoral vein and artery. The operative sites were infiltrated with 1% xylocaine and closed with wound clips. A loose-fitting plaster cast was applied around the trunk and hindlimbs for restraint. This arrangement permitted free movements of head and forelimbs. Body temperature was monitored via a rectal thermo probe connected to a thermostatic de vice (Harvard, U.K.), which activated an external warm ing element when body temperature decreased to <35.5°C. Mean arterial blood pressure and heart rate were assessed before and at fixed times after drug treat ment by connecting the arterial catheter to a pressure transducer (Barovar, Alvar Electronic, France), which was attached to a paper chart recorder (Gould Inc., U.S.A.). Baseline and subsequent measurements of plasma glucose concentration were made throughout the experiment (Glucose Analyzer II, Beckman, U.S.A.). Hematocrit was determined before the injection of [14CJDG. Animals were excluded from the study if base line values were outside of the following limits: mean arterial pressure, 90-130 mm Hg; temperature, 35-38°C; plasma glucose concentration, 100-200 mg/dl.
After a 4-h recovery period, [l4CJDG 125 J-lCi/kg was administered by rapid i. v. bolus injection. Arterial blood samples (l00 J-ll) were taken at 6,18,30 s and I, 3, 5, 7.5, 15, 25, 35 , and 45 min after [14CJDG injection. Samples were centrifuged immediately, and plasma radioactivity (liquid scintillation counter 1209 LKB Wallac, U.S.A.) and glucose concentration were measured. Animals were killed 45 min after [14CJDG by an overdose of pentobar bital. Brains were removed rapidly and frozen in isopen-J Cereb Blood Flow Metab, Vol. 15, No.6, 1995 tane chilled with dry ice at -45°C and then stored at -70°e. Coronal brain sections (20 J-lm thick) were cut on a cryostat (Reichert-Jung, Cambridge Instrument, Ger many) at -20°e. Sections were mounted on coverslips and dried immediately at 55°C on a hot plate. Autoradio graphs were then prepared by exposing X-AR5 x-ray film (Kodak) to the mounted sections and [14CJmethyl methacrylate standards (Amersham) for 7 days.
Autoradiograms were analyzed by quantitative densi tometry with a computerized image-processing device (Biocom. France). To identify brain structures and corti cal layers. sections adjacent to those used for autoradi ography were stained with cresyl violet. Stained sections and corresponding sections in the autoradiogram were superimposed. and the delineation of the structures was made according to the atlas of Paxinos and Watson (1986) . The neocortex was divided into superficial layers (layers I. II and upper part of layer III). middle layers (lower part of layer III. and layer IV). and deep layers (layers V and VI). Five separate optical density measure ments for each structure were made in consecutive brain sections. As right-left differences were sometimes found. only measurements in the left hemisphere were consid ered. Tissue 14C concentrations were determined from the optical densities. and a calibration curve was obtained by a densitometric analysis of the autoradiograms of the calibrated standards. LCGU was then calculated from the local tissue 14C concentrations. the time course of the plasma [14CJDG and 'glucose concentration. and appro priate kinetic constants according to the operational equation published by Sokoloff et al. (1977) . For each rat and each brain region. LCGU value was calculated as the arithmetic mean of five independent measurements.
Time course of drug effects
To inject the rI4C]DG at the peak of the drug effects. a pilot experiment had been performed to determine the time course of the behavioral effects of both drugs. Aged rats received in i.p. injection of THA (10 mg/kg. n = 5) or of PHY (0.5 mg/kg. n = 5). Control rats (n = 5) received an equal volume of saline. Central body temperature was assessed at fixed times (10 min) during 2 h for PHY and 3 h for THA. Behavioral signs were quantified at fixed times by a single experimenter who rated each animal on a scale of 0 (no effect) to + + + (maximum effect). THA and PHY induced the same types of behavioral effects (Table I ) but with different time courses. On the basis of these observations. PHY and THA were injected 10 and 50 min. respectively. before [14CJDG.
Drug treatments
LCGU was assessed in three groups of seven rats. To block the peripheral effects of anticholinesterases. ani mals were pretreated with hexamethonium bromide (5 mg/kg i.p.) and atropine methylbromide (4 mg/kg s.c.) 30 and 20 min. respectively. before drug administration. An imals then received an i.p. injection of isotonic saline (control group) or THA (10 mg/kg) or PHY (0.5 mg/kg).
Statistical analysis
Physiological parameters were compared between 27-month-old control and treated rats by one-way analysis of variance (ANOV A) followed by Dunnett's test. Within each experimental grouP. physiological parameters at dif ferent times after [14CJDG were compared using paired samples t test. For each brain region, Leau values from 27-month old control and treated rats were analyzed by one-way ANOV A followed by a Dunnett's test, for multiple com parisons (Tables 3-5 ). Then LeaU values were subjected to two-way (region, drugs) ANOV A.
For each brain region, Leau values from 3-and 27-month-old controls rats were compared by one-way ANOV A followed by a Dunnett's test. Then LeaU val ues were subjected to two-way ANOV A (age, treatment). Differences were considered significant if p < 0.05.
creased in THA-and PHY-treated rats (p < 0.001), and arterial pressure and plasma glucose concentra tion increased in PHY-treated rats. However, phys iological parameters in treated rats were within the required limits of Sokoloff's method.
RESULTS
Physiological parameters during the
Cerebral glucose utilization in 27-month-old rats under basal conditions
As compared to control rats (Table 2) , body tem perature decreased in THA-treated rats (p < 0.01) and mean arterial pressure and plasma glucose con centration increased in PHY -treated rats (p < 0.001, p < 0.05, respectively). As corripared to the baseline conditions (Table 2 ), body temperature deAs compared with 3-month-old rats previously studied under identical experimental conditions, the average hemispheric LCGU (unweighted arithmetic mean of LCG U in all the regions studied) was sig nificantly reduced by 10% (p < 0.01) in 27-month· old rats (78 ± 22 and 70 ± 20 f.1molllOO g/min, re spectively). LCGU reduction in aged rats was not evenly distributed in the brain but restricted to spe cific regions (20 of the 54 regions studied; Fig. 1 ). In these regions, LCGU decreased in old rats by 10 to 24% as compared to young controls (average de- Average increase in LCGU in 27-month-old rats treated by tacrine (THA; black bar) or physostigmine (PHY; hatched bar; LCGU values shown as percentage of age-matched control mean values). In the large majority of the regions where an effect of the drugs is found, increase in LCGU compensates for or exceeds the age-related hypometabolism A: Cortical areas (F, frontal; Ins, insular; R, retrosplenial; 0, occipital, T, temporal; E, entorhinal; Pr, perirhinal). B: Subcortical areas (CPu, caudate-putamen; GP, globus pallidus; VTA, ventral tegmental area; SNc, substantia nigra (pars compacta); SNr, substantia nigra reticulata; MS, medial septum; HV" ventral hippocampus (CA,); SC, superior colliculus; IP, interpeduncular nucleus.
crease of 17%). In the cortical areas, significant de creases were found in the prefrontal, insular, retro splenial, occipital, entorhinal, perirhinal, and tem poral cortices (Figs. 2B and 3B) . LCGU was unchanged in the limbic regions, with the exception of the medial septum and the ventral hippocampal CAl field (Fig. 2B ). In the diencephalon (ventral thalamus, reticular thalamic nucleus, hypothala mus, lateral habenula) and in the cerebellum, LCGU remained unchanged, whereas it was re duced in the nigrostriatal system (substantia nigra, globus pallidus, and caudate putamen) (Figs. 2B and 3B), the ventral tegmental area, and the supe rior colliculus (Fig. 2B) . These results are in agree ment with those published previously (Bassant et aI., 1994) .
Effects of THA on LCGU 27-Month-old rats. THA significantly increased LCG U in 13 of the 54 regions studied (24%) (Tables J Cereb Blood Flow Me/ab, Vol. 15, No. 6. 1995 3-5). In these regions, average THA-induced in crease in LCGU was 24% of the age-matched con trol. In the cortical areas, the largest increases were found in the temporal (36%), insular (26%) and ret rosplenial cortices (23%; Table 3 ). In the subcorti cal areas, pronounced effects were observed in the diagonal band of Broca (22%), in the superior col liculus (30%), the reticular thalamic nucleus (27%), and the subiculum (21%; Tables 4 and 5, Fig. 1A and B, Fig. 2D ). The average hemispheric LCGU (74 ± 24 f,Lmo1l100 g/min) increased by 5% as com pared to age-matched controls (70 ± 20 f,Lmol/100 g/min; not statistically significant).
Three-month versus 27-month-old rats. In 3-month-old rats, THA induced significant in creases in LCGU in 23 of the 54 regions studied (42%). In these regions, the average increase was 28% of control. The hemispheric (whole brain) LCGU of THA-treated rats increased by 15% as compared to age-matched controls (p < 0.01, Dun- CONTROL A nett's test). In 27-month-old rats, LCG U increased in a smaller number of regions (13 vs. 23 in young rats). The metabolic activation induced by THA was no longer observed in the septal nuclei (medial septum, horizontal limb of the diagonal band of Broca), the hippocampus (dorsal and ventral CA3 fields, dentate gyrus), the basolateral amygdala, and the substantia nigra (Fig. 2D) . The interaction between age and treatment was assessed by a two way ANOVA. The averag e hemispheric LCGU differed significantly between young and old treated rats (p < 0.002). Age effect (lower response in aged rats) was observed in the insular cortex (p < 0.01), the superficial (p < 0.01) and deep layers In the 20 regions where a significant age-related decrease in LCGU occurred (Fig. 1) , THA re mained active in seven regions, where it compen sated for the age-related decrease in LCGU or ex ceeded the young control values (middle layer of the temporal cortex, superior colliculus).
Effects of PHY on LCGU
27-month-old rats. PHY significantly increased LCGU in 10 of the 54 regions studied (18%). In these regions, average PHY -induced increase in Regions with significant age-related hy pometabolism are indicated by an aster isk. Right: PHY-induced increase in LCGU in 3-month-(C) and 27-month-old (0) rats. Regions with significant increase in LCGU are indicated by arrows. C, cin gulate cortex; Ins, insular cortex; CPu, caudate-putamen; GP, globus pallid us; DBBh, diagonal band of Broca (horizon tal limb); PO, preoptic area (magnocellu lar). Notice that the effect of PHY is not found in the preoptic area, the diagonal band of Broca, and the cingulate cortex of the 27-month-old rat, whereas the drug is still active in the insular cortex. THA, tacrine; PHY, physostigmine. Values are mean LCGU ± SD. Statistical differences between controls and treated groups were calculated by one-way analysis of variance followed by Dunnett't test. " p < 0.05. h P < 0.01.
LCGU was 23% of age-matched control. Largest increases were found in the superior colliculus (56%), the insular cortex (38%), the thalamus (36%) and the lateral habenula (29%; Tables 3-5). Average hemispheric LCGU (75 ± 24 J-lmoIllOO g/min) in creased by 7% as compared to age-matched control (p < 0.05, Dunnett's test).
Three-month versus 27-month-old rats. In 3-month-old rats, PHY -induced significant in creases in LCG U in 23 of the 54 regions studied (42%). In these regions, the average increase was 29% of control. The hemispheric (whole brain) LCGU of PHY-treated rats increased by 13% as compared to control (p < 0.01, Dunnett's test). In 27-month-old rats, LCGU rose in a smaller number of regions (10 vs. 23 in young rats). The metabolic activation induced by PHY was no longer observed in the magnocellular preoptic area, the horizontal limb of the diagonal band of Broca (Fig. 3D) , the basolateral amygdala, the interpedundular nucleus, and the pontomesencephalic cholinergic nuclei. Two-way ANOVA showed that the average hemi spheric LCGU differed significantly between young J Cereb Blood Flow Metab, Vol. 15, No.6, 1995 and old PHY-treated rats (p < 0.05). A significant interaction between age and treatment was found in the superior colliculus (p < 0.05), the reticular tha lamic nucleus (p < 0.01), and the central gray mat ter (p < 0.01). In contrast, PHY -induced increase in LCGU was the same at both ages in the medial septum, the horizontal limb of the diagonal band of Broca, and the insular cortex.
In the 20 regions with an age-related decrease in LCG U, PHY retained activity in four regions, with a dramatic effect in the insular cortex and superior colliculus (Fig. I) .
Comparison of the effects of THA and PHY
The percentages of the regions where THA and PHY increased LCGU (24 and 18%, respectively) were not statistically different (chi-square test). The average drug-induced increases in LCGU were sim ilar (24 and 23%, respectively). A two-way ANOV A performed on all the regions studied showed a sig nificant interaction between drugs and regions (p < 0.001), indicating that the level of drug effects dif fered among regions. Significant differences were found in the parietal, . sensorimotor and temporal cortex, the, substantia nigra, and the central gray matter.
In 3-month-old rats, the effects of THA and PHY 
. coincided in 17 regions. The vast majority of the regions where a drug-induced increase in LCGU was found in 27-month-old rats belonged to the group of the 17 regions where both drugs were ac tive in 3-month-old rats (insular and retrosplenial cortices, vertical limb of the diagonal band of Broca, thalamic nuclei, lateral habenula, substantia nigra pars compacta, and superior colliculus). In the remainder of the 17 regions (cingulate cortex, hor izontal limb of the diagonal band of Broca, ventral hippocampus (CA3) and basolateral amygdala), both THA and PHY failed to increase LCG U III aged rats.
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Medial
DISCUSSION
THA and PHY increase LCGU in a sizable num ber of brain regions in the aged rat. It is interesting to note that both drugs are still significantly active in regions where an age-related hypometabolism oc curs. For example, the hypometabolism is com pletely compensated by THA in cortical areas such as insular, retrosplenial, and temporal cortices. In the medial septum, the insular cortex, and the su perior colliculus, the balance between the effect of PHY and the age-related hypometabolism results in large increases in LCG U, which exceed the young control values. However, as compared to young rats, aged rats are less sensitive to THA and PRY. The drug-effects are smaller, in. terms of both aver age hemispheric LCGU and number of regions af fected. In the large majority of these regions, the metabolic activation is lower in aged as compared to young rats.
Pharmacokinetics
The brain pharmacokinetics of THA and PHY were not measured in our experiment, but our be havioral study demonstrated that the peak effect and the amplitude of the behavioral signs were sim ilar in young and aged rats treated with the same dose of anticholinesterases (THA, 10 mg/kg; PHY, 0. 5 mg/kg). Consequently, doses and delays be tween injections of drugs and [ 14 C]DG were the same in both groups. The fact that in a limited num ber of regions, the drug-induced increase in LCGU was the same in the two age groups, suggests that the brain concentration of the drugs during the [ 14 C]DG experiment was probably similar in 3-and 27-month-old rats. However, the peak time of de crease in central body temperature was delayed in aged as compared to young rats (data not shown). This might indicate a slower drug clearance from the brain, resulting in higher brain concentration. Drug clearance is often altered with aging, reflect ing reduced metabolism or excretion at peripheral sites such as liver or kidney or both (Corman et aI., 1985) .
Effect of THA
The effects of THA in the central nervous system are complex. In addition to an inhibitory effect on AChE, THA interacts with muscarinic and nicotinic receptors (Perry et aI. , 1988; Hunter et aI., 1989) and modulates the release of acetylcholine (ACh) (Nilsson et aI., 1987) . THA has also an effect on monoaminergic systems by blocking monoamine re lease and uptake (Drukarch et aI., 1988) and by in hibiting the enzyme monoamine oxidase (Adem et aI., 1989) . Finally a direct blocking action of THA . on potassium and sodium channels has been reported (Rogawski, 1987; Stevens and Cotman, 1987; Halliwell and Grove, 1989; Dutar et al., 1990) . Some of these mechanisms of action could increase neuronal activity and therefore raise the cerebral metabolism. For instance, the blockade of the ),-aminobutyric acid B (GABA-B) inhibitory postsynaptic potentials (lPSPs) would increase neu ronal discharge rate and thus glucose utilization (Dutar et aI., 1990) . However, the fact that THA increases LCG U in defined cortical and subcortical areas suggests that it is not acting on the brain in an unspecific manner. Effects of THA on LCGU might be due to its cholinergic properties. In this case, one might expect to find correlations between LCGU increase and the topography of cholinergic markers such as choline acetyltransferase (ChAT), AChE, cholinergic receptors, density of cholinergic termi nals, or cholinergic neurons. Previous results in young rats suggest that the effects of THA as well as those of PHY on LCG U are indeed related to the regional distribution of AChE activity and of M2 receptors (Bassant et aI. , 1993) . It has been sug gested that an interaction of THA with M2 receptors could play a role in its therapeutic effects. Perry et al. (1988) showed that THA displaces muscarinic ligand binding in human cerebral cortex. This prop erty may be therapeutically relevant by blocking the feedback inhibition of ACh release via presynaptic M2 muscarinic receptors. This hypothesis was also proposed by Adem et al. (1990) , who reported that THA increases the release of ACh in cortical tissue slices from Alzheimer disease brains. However, no effect of THA on muscarinic receptors has been observed in the rat hippocampal slice (Dutar et aI. , 1990) . Pearce and Potter (1988) found that "clini cally effective" concentrations of THA inhibited AChE but did not alter agonist interactions with muscarinic receptors. It is therefore probable that the metabolic activation is mainly due to the anti cholinesterase activity of THA. However, we can not exclude that the effects of THA might be medi ated partly via interactions with muscarinic recep tors.
In agreement with our previous findings in young rats, these results show that a large majority of the regions (11 of 13) where THA increases LCG U in aged rats have a high AChE activity and a high M2 receptor density in the young animal (Paxinos and Watson, 1986; Mash and Potter, 1986) . However, THA effects are no longer observed in some regions (medial septum, horizontal limb of the diagonal band of Broca, dorsal hippocampus) where high AChE activity and M2 receptor density have been described in young rats. The weaker effect of THA in specific regions may be associated with age dependent deficits in cholinergic transmission. A number of studies have examined the effects of ag ing on cholinergic markers in the rat brain. Data concerning ChAT and AChE activity are controver sial (for review, see Decker, 1987) . The inconsis tency of the results suggests that age-related changes in ChAT and AChE activity are, at most, small and not likely to be responsible for the loss of anticholinesterase effects on LCG U in specific brain areas.
J Cereb Blood Flow Metab, Vol. 15, No.6, 1995 Decreases in the number or size or both of basal forebrain cholinergic neurons have been reported in the aged rat. Some authors demonstrated a signifi cant reduction in the number of cells (Biegon et aI., 1989; Fisher et aI., 1989; de Bilbao et aI., 1991) , whereas other authors observed only a small loss or no difference in the cell number but a decrease in size (see ref. in Decker, 1987) . It is conceivable that a loss of cholinergic neurons, even if not extensive, and the resulting decrease of cholinergic input to the hippocampus and neocortex could alter the ef fect of THA and PHY by reducing the availability of ACh at the synapse. Indeed, our results show that the THA-induced increase in LCGU is suppressed or diminished mainly in projection fields of cholin ergic basal forebrain neurons. There is evidence to indicate that the rate of ACh synthesis decreases with advancing age (see ref. in Mc Entee and Crook, 1992) . On the other hand, studies on ACh release have shown that the depolarization-induced and the basal release of ACh are significantly de creased in synaptosomal preparations of cerebral cortex and hippocampus from aged rats (Araujo et aI. , 1990) and that basal ACh release is decreased in cortex an d' hippocampus in freely moving rats (Wu et aI., 1988) . It is then possible that the efficacy of AChE inhibitors may decline with age as a result of reduced ACh release.
Our results could also reflect an altered response to cholinergic agonists (Lippa et aI. , 1987; Segal, 1982; Potier et aI. , 1992) . This alteration can be ex plained by a loss of cholinergic receptors or a de creased affinity of the agonist for the receptor or a decreased efficacy of the receptor or a combination of these (for example, in terms of transduction mechanisms).
No change in muscarinic receptor affinity has been reported in the cerebral cortex of the aged rat (Schwartz et aI. , 1990) . Studies of muscarinic recep tor density have yielded conflicting results. Possible reasons for the discrepancies are differences in re ceptor subtype, strain, and age. No age-related change in muscarinic receptor density has been ob served in Sprague-Dawley rats (Strong et aI., 1980; Michalek et aI. , 1989) . However, a decrease in M2 binding with aging has been reported in other strains (Biegon et aI. , 1989; Araujo et aI., 1990) , whereas M 1 receptor seems to be less susceptible to the effects of age (Araujo et al. , 1990) . Reduction of M2 binding was observed in some of the regions where the effects of THA are no longer found in our experiment. This correlation is far from perfect be cause M2 receptor density is not affected by age in other regions (CA3 field of the dorsal hippocampus, dentate gyrus, basolateral amygdala) where the ef-fect of THA disappears. Furthermore, THA re mains active in brain areas with an age-related de crease in M2 receptor density, such as ventral hip pocampus, subiculum, and the vertical limb of the diagonal band of Broca. Therefore, it seems un likely that the differences between the effects of THA in young and aged rats can be explained by a decrease in receptor density.
Defective coupling of postsynaptic mechanisms may alter muscarinic function in the aged brain. Among several second-messenger systems, musca rinic receptors mediate activation or inhibition of the phosphatidylinositol hydrolysis. Surichamorn et al. (1989) found that phosphatidylinositol hydroly sis, in response to activation of muscarinic recep tor, does not change with aging in various brain areas, including cortex, hippocampus, and thala mus. No decline with age was detected in the effect of the cholinergic agonist arecoline on LCG U in 24-month-old Fisher-344 rats (Soncrant et aI., 1989) . According to the authors, the invariant met abolic response to arecoline implies that the func tion of muscarinic receptors and postreceptor mechanisms remains intact during senescence. The loss of effectiveness of THA in the aged brain prob ably does not result from abnormal postsynaptic coupling but rather from a lower amount of ACh at the synaptic level, which reduces the importance of an anticholinesterase action.
Effect of physostigmine
The age-related reduction of the effect of PHY is almost identical to that of THA and probably results from the same mechanisms. In the young control, PHY (but not THA) increases LCGU in the cere bellum (interpositus nucleus) and in regions con taining cholinergic projection neurons (magnocellu lar preoptic area, pontomesencephalic cholinergic nuclei) or receiving an abundant cholinergic inner vation (interpedundular nucleus, central gray mat ter; Bassant et aI., 1993) . Because PHY is a refer ence AChE inhibitor, it is conceivable that its ef fects in these "specific" regions are due to an anticholinesterase action. In 27-month-old rats, ef fects of PHY are no longer observed in these re gions, with the exception of the central gray matter, where a small effect remains. This finding indicates that it is relevant to link age-related loss of meta bolic effect of PHY (and, by extension, of THA) with altered anticholinesterase action.
CONCLUSION
Our results show that (a) THA and PHY are still active in aged rats; (b) both drugs have roughly sim ilar effects, compatible with AChE inhibition; (c) as compared to young rats, drug-induced increase in LCGU is reduced, both in terms of amplitude of the response and number of regions affected; and (d) in some regions, THA and PHY can compensate for the age-related hypometabolism. It is interesting to note that the temporal and parietal cortices, which show the most consistent LCGU alterations in Alz heimer's disease (Foster et aI., 1984) , are among the regions that remain "sensitive" to THA in the aged rat. THA treatment increases glucose utilization in AD patients in cortical (frontal and temporal corti ces) and subcortical areas (Nordberg et aI., 1992; Nordberg, 1993) . PHY and THA improve memory deficits in nucleus basalis-Iesioned rats (Murray and Fibiger, 1985; K wo-On-Yuen et aI., 1990) and in memory-impaired aged monkeys (Bartus and Dean, 1988) . It would be interesting to know if LCGU is modified in parallel with behavioral im provement in these animals. The fact that a meta bolic activation is still observed in the aged brain in some parts of the septohippocampal system, in the subiculum, and in the cortex suggests that THA and PHY are still able to increase neuronal activity in regions involved in cognitive functions. Such an in crease in LCG U might occur in Alzheimer patients receiving THA and participate in the cognitive im provement.
